• Home
  • News
  • Get involved
  • About NICE
  • Find guidance
  • NICE Pathways
  • Quality standards
  • Into practice
  • QOF
  • Conditions and diseases

    • Blood and immune system
    • Cancer
    • Cardiovascular
    • Central nervous system
    • Digestive system
    • Ear and nose
    • Endocrine, nutritional and metabolic
    • Eye
    • Gynaecology, pregnancy and birth
    • Infectious diseases
    • Injuries, accidents and wounds
    • Mental health and behavioural conditions
    • Mouth and dental
    • Musculoskeletal
    • Respiratory
    • Skin
    • Urogenital
  • Public health

    • Accidents and injuries
    • Alcohol
    • Behaviour change
    • Cancer
    • Cardiovascular disease
    • Child health
    • Child social care
    • Chronic illness
    • Diabetes
    • Drugs
    • Environmental health
    • Infectious diseases
    • Maternal health
    • Mental health
    • Non-communicable diseases
    • Obesity and diet
    • Occupational health
    • Older people
    • Physical activity
    • Sexual health
    • Smoking and tobacco
    • Transport
    • Vaccine preventable diseases
    • Working with and involving communities
  • Treatments, Procedures and Devices

    • Bones and joint surgery
    • Cardiovascular surgery
    • Cardiovascular system drug treatments
    • Clinical devices
    • Diagnostic imaging
    • Diagnostic procedures
    • Digestive tract and other abdominal organs surgery
    • Drug treatments
    • Endocrine system and breast surgery
    • Eye surgery
    • Nervous system surgery
    • Radiotherapy
    • Screening
    • Surgical procedures
    • Therapeutic procedures
    • Tissue and organ donation
    • Urogenital surgery
  • Guidance by type

    • Clinical Guidelines
    • Technology appraisals
    • Public health guidance
    • Diagnostics guidance
    • Interventional procedures guidance
    • Medical technologies guidance
    • Cancer service guidance
    • Quality standards
  • Guidance by date

    • View the guidance by date published
About NICE guidance Close
NICE technology appraisal guidance
Issued: March 2008
TA138

Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over

Select chapters to print, save or share
Important information about this guidance
1 Guidance
2 Clinical need and practice
3 The technologies
4 Evidence and interpretation
5 Implementation
6 Related NICE guidance
7 Review of guidance
Appendix A: Appraisal Committee members and NICE project team
Appendix B: Sources of evidence considered by the Committee
Appendix C: Products included in appraisal
  • Download PDF PDF icon
  • Download Word documentMicrosoft Word document icon
  • Help
View the summary and implementation tools
Next

This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ta138

Important information about this guidance

This guidance was developed using the NICE multiple technology appraisals process: www.nice.org.uk/aboutnice/howwework/devnicetech/developing_nice_multiple_technology_appraisals.jsp

Next

Copyright © NICE 2013. All rights reserved.

Index